Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens

Cancer Immunity

Volumn 1, Issue , 2001, Pages 1-10

  Wolchok, Jedd D ^a   Srinivasan, Roopa ^a   Perales, Miguel Angel ^a   Houghton, Alan N ^a   Bowne, Wilbur B ^a   Blachere, Nathalie E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

DNA vaccine; IFN gamma; Immunological adjuvant; Immunotherapy; Mice; Tyrosinase related protein

Indexed keywords

ANTIGEN; AUTOANTIBODY; CANCER ANTIBODY; DNA VACCINE; GLYCOPROTEIN; INTERLEUKIN 4; RECOMBINANT GAMMA INTERFERON; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DEPIGMENTATION; EXPERIMENTAL MODEL; FEMALE; GENETIC CODE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; KNOCKOUT MOUSE; MELANOMA; MELANOSOME; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUMOR IMMUNITY;

EID: 1942426429     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Weber LW, Bowne WB, Wolchok JD, Srinivasan R, Qin J, Moroi Y, Clynes R, Song P, Lewis JJ, Houghton AN. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest 1998; 102:1258-64. (PMID: 9739060)
2. Bowne WB, Srinivasan R, Wolchok JD, Hawkins WG, Blachere NE, Dyall R, Lewis JJ, Houghton AN. Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med 1999; 190:1717-22. (PMID: 10587362)
3. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-95. (PMID: 9143706)
4. Kamijo R, Shapiro D, Gerecitano J, Le J, Bosland M, Vilcek J. Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice. Hokkaido Igaku Zasshi 1994; 69:1332-8. (PMID: 7705746)
5. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:1435-40. (PMID: 8376946)
6. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259:1742-5. (PMID: 8456301)
7. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med 1993; 178:1725-32. (PMID: 8228818)
8. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7. (PMID: 8245795)
9. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54. (PMID: 7504064)
10. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259:1739-42. (PMID: 8456300)
11. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994; 179:1367-71. (PMID: 7908325)
12. Winter H, Hu HM, McClain K, Urba WJ, Fox BA. Immunotherapy of Melanoma: A Dichotomy in the Requirement for IFN-gamma in Vaccine-Induced Antitumor Immunity Versus Adoptive Immunotherapy. J Immunol 2001; 166:7370-7380. (PMID: 11390488)
13. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 1998; 188:2357-68. (PMID: 9858522)
14. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 1998; 95:7556-61. (PMID: 9636188)
15. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410:1107-11. (PMID: 11323675)
16. Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT, Tao MH. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998; 160:1320-9. (PMID: 9570550)
17. Lim YS, Kang BY, Kim EJ, Kim SH, Hwang SY, Kim TS. Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct. Immunology 1998; 94:135-41. (PMID: 9741333)
18. N. Blachere et al. Manuscript in preparation.
19. Bowne WB, Wolchok JD, Hawkins WG, Srinivasan R, Gregor P, Blachere NE, Moroi Y, Engelhorn ME, Houghton AN, Lewis JJ. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects. Cytokines Cell Mol Ther 1999; 5:217-25. (PMID: 10850386)
20. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 1996; 93:2879-83. (PMID: 8610135)
21. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996; 273:352-4. (PMID: 8662521)
22. Su Z, Stevenson MM. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect Immun 2000; 68:4399-406. (PMID: 10899836)
23. Hara I, Nguyen H, Takechi Y, Gansbacher B, Chapman PB, Houghton AN. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection. Int J Cancer 1995; 61:253-60. (PMID: 7705956)
24. Bloom MB, Perry-Lalley D, Robbins PF, Li Y, el-Gamil M, Rosenberg SA, Yang JC. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med 1997; 185:453-9. (PMID: 9053445)
25. Ross HM, Weber LW, Wang S, Piskun G, Dyall R, Song P, Takechi Y, Nikolic-Zugic J, Houghton AN, Lewis JJ. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin Cancer Res 1997; 3:2191-6. (PMID: 9815614)
26. Kyuwa S, Tagawa Y, Shibata S, Doi K, Machii K, Iwakura Y. Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon. J Virol 1998; 72:9286-90. (PMID: 9765476)